The groundbreaking treatment of this peptide represents a major breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide781151.digitollblog.com/41948214/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment